Q2 2025 · 13F-HR
PFIZER INC (PFE)holdings as filed
Filed 2025-08-11 · accession 0000078003-25-000142
$576.2M
Reported value
21
Positions
2025-06-30
Period end
The Brief · PFIZER INC (PFE) · Q2 2025
AI · grounded in 13F
PFIZER INC (PFE) established a new position in BIONTECH SE BNTX valued at $389.5M. The fund also initiated new stakes in ORIC PHARMACEUTICALS INC ORIC for $54.6M and ARVINAS INC ARVN for $25.4M. Additional new positions include ALLOGENE THERAPEUTICS INC ALLO and TOURMALINE BIO INC TRML.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 09075V102 | BNTX | BIONTECH SE | $389.5M | 67.6% | 3,658,361 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $54.6M | 9.47% | 5,376,344 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $25.4M | 4.42% | 3,457,815 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $24.9M | 4.32% | 22,032,040 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $20.3M | 3.53% | 1,272,214 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $12.2M | 2.12% | 1,875,000 | Common | SHARED |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $7.7M | 1.34% | 7,032,770 | Common | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $7.6M | 1.32% | 2,411,575 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $7.1M | 1.24% | 505,645 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $6.9M | 1.19% | 2,362,348 | Common | SOLE |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $5.9M | 1.03% | 4,690,431 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $4.7M | 0.81% | 349,406 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $3.1M | 0.54% | 2,970,022 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $2.8M | 0.49% | 1,675,000 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $1.1M | 0.19% | 953,834 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $870,206 | 0.15% | 157,646 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $758,213 | 0.13% | 715,295 | Common | SHARED |
| 746964105 | QTTB | Q32 BIO INC | $413,888 | 0.07% | 277,777 | Common | SOLE |
| 097702203 | BOLT | BOLT BIOTHERAPEUTICS INC | $180,630 | 0.03% | 31,305 | Common | SHARED |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $32,940 | 0.01% | 2,928 | Common | SOLE |
| 81727U105 | SENS1GBP | SENSEONICS HLDGS INC | $20,671 | 0.00% | 43,426 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.